Manulife (Manufacturers Life Insurance)’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-25,210
Closed -$29.2K 3097
2023
Q1
$29.2K Hold
25,210
﹤0.01% 2899
2022
Q4
$67.6K Buy
25,210
+1,579
+7% +$4.16K ﹤0.01% 2880
2022
Q3
$67.6K Sell
23,631
-152
-0.6% -$646 ﹤0.01% 2889
2022
Q2
$118K Buy
23,783
+3,067
+15% +$16.1K ﹤0.01% 2854
2022
Q1
$147K Sell
20,716
-4,687
-18% -$38.8K ﹤0.01% 2875
2021
Q4
$462 Buy
25,403
+62
+0.2% +$1.34K ﹤0.01% 2317
2021
Q3
$496K Sell
25,341
-1,379
-5% -$52.4K ﹤0.01% 2292
2021
Q2
$1.2M Buy
+26,720
New +$1.24M ﹤0.01% 1883

Other funds holding CELL

Manulife (Manufacturers Life Insurance)'s CELL Position: Q2 2023 in Review

Manulife (Manufacturers Life Insurance) sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2023, closing a stake of 25,210 shares — an estimated $29.2K sold.

Manulife (Manufacturers Life Insurance) first reported a position in CELL in Q2 2021 and held it in 8 quarters. The position peaked at $1.2M in Q2 2021. 84 funds tracked by Wall St. Rank hold CELL as of Q2 2023.

  • Manulife (Manufacturers Life Insurance) reported no remaining PhenomeX Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 25,210 PhenomeX Inc. Common Stock shares in Q2 2023, an estimated $29.2K.
  • Manulife (Manufacturers Life Insurance) first reported a position in PhenomeX Inc. Common Stock in Q2 2021 and held it in 8 quarters.
  • Manulife (Manufacturers Life Insurance)'s PhenomeX Inc. Common Stock position peaked at $1.2M in Q2 2021.
  • 84 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2023.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2023, filed 11 Aug 2023.